Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-09-11

Clinical Trial Update: Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update studying anti-Mullerian hormone (AMH) levels during ovarian stimulation with gonadotropins in infertility.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Athens | Conditions: Female Infertility | Phase 2, Phase 3 | Status: UNKNOWN